Drotaverine hydrochloride is a selective phosphodiesterase 4 inhibitor classified as an antispasmodic agent, widely used to treat smooth muscle spasms, including those associated with dysmenorrhea, colic,… Read more
Drotaverine hydrochloride is a selective phosphodiesterase 4 inhibitor classified as an antispasmodic agent, widely used to treat smooth muscle spasms, including those associated with dysmenorrhea, colic, and cervical dilation during childbirth. Laboratories rely on high-quality reference standards for this active pharmaceutical ingredient to ensure the accuracy and reliability of analytical procedures. The product list encompasses a comprehensive selection of identified impurities, process-related byproducts, and metabolites, as well as stable isotope-labelled compounds essential for rigorous analytical testing. These materials are critical for accurate impurity profiling, method validation, and consistent quality control within pharmaceutical research and manufacturing environments. By utilizing these precise standards, scientists can effectively monitor, identify, and quantify components in drotaverine hydrochloride formulations, maintaining compliance with stringent regulatory and pharmacopeial requirements throughout the drug development lifecycle.
